Please use this identifier to cite or link to this item:
Publication type: Conference poster
Type of review: Peer review (abstract)
Title: Beliefs about medicines in patients with multiple myeloma in Switzerland
Authors: Altwicker-Hámori, Szilvia
Juvalta, Sibylle
Bargetzi, Mario
Renner, Christoph
Taverna, Christina
Dratva, Julia
et. al: No
DOI: 10.4414/smw.2021.w30107
Published in: Swiss Medical Weekly
Volume(Issue): 151
Issue: Supplementum 255
Page(s): 28
Pages to: 29
Conference details: 4th Swiss Oncology & Hematology Congress (SOHC), Zurich, 18-20 November 2021
Issue Date: 18-Nov-2021
Publisher / Ed. Institution: EMH Swiss Medical Publishers
ISSN: 2504-1622
Language: English
Subject (DDC): 616: Internal medicine and diseases
Abstract: Background: Medication beliefs have been found to be associated with medication adherence among various cancer patients. Despite its importance, medication beliefs have not been investigated in patients with multiple myeloma (MM). A study on quality of life in MM patients provided the opportunity to fill this gap. Methods: Patients were recruited consecutively from three Swiss oncology/hematology centres. Inclusion criteria included confirmed histological MM diagnosis, age ≥18 years and informed consent. Exclusion criteria were participation in another clinical study, inability to communicate in German and more than one cancer diagnosis. Participants completed a survey including the Beliefs about Medicines Questionnaire (BMQ) and a sociodemographic questionnaire. Clinical data was extracted from medical records. The complete case dataset (N = 41) was analysed using descriptive statistical methods. Results: Most participants were men (59%), married/partnered (80%), born in Switzerland (80%), economically inactive (85%) and completed at most upper secondary education (72%). Mean age at diagnosis was 61 years (range: 35-81 years). 48% of the participants were in a stable/plateau phase, 37% in a relapsed/progressive phase and 15% newly diagnosed; 96% had good ECOG performance status. Table 1 presents the results of the BMQ. The vast majority of the sample believed in the necessity of their medication for maintaining their health; however, 70% reported concerns about their long-term effects. The specific-necessity subscale and general-harm subscale showed the highest and lowest mean, respectively. Conclusions: The results indicate higher necessity beliefs than concerns towards MM medication. Specific items point to topics to be raised by treating physicians.
Fulltext version: Published version
License (according to publishing contract): CC BY-NC-SA 4.0: Attribution - Non commercial - Share alike 4.0 International
Departement: School of Health Sciences
Organisational Unit: Institute of Public Health (IPH)
Published as part of the ZHAW project: Lebensqualität bei Myelom Patientinnen und Patienten in drei Schweizer Kliniken
Appears in collections:Publikationen Gesundheit

Files in This Item:
File Description SizeFormat 
2021_AltwickerHamori-etal_Beliefs-about-medicine-myeloma-patients-CH.pdf155.8 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.